http://www.ft .com/intl/fastft/330581
"Cellectis, the French biotech company, is in talks about its potential sale, with Pfizer of the US considered to be among the buyers.
Two people familiar with the situation said Cellectis was in negotiations over a deal, but warned no outcome was certain, report Bryce Elder, Arash Massoudi and Andrew Ward in London and David Crow in New York.
One person said Pfizer has approached the company about a deal that could value it at as much as €1.5bn."
---------------
http://forum.hardware.fr/hfr/Discu [...] 2237_1.htm